Europe Continuous Glucose Monitoring Systems (CGMS) Market

Europe Continuous Glucose Monitoring Systems (CGMS) Market Overview

The Europe Continuous Glucose Monitoring Systems (CGMS) market was estimated to attain a market size of $3 billion in 2015 and is expected to grow at a CAGR of 5.4 % during the forecast period (2016 – 2022).

The U.S region would continue its dominance and would attain a market size of $2.9 billion by 2022. The Drug Eluting Stents segment is expected to further grow at a CAGR of 4.6% during the forecast period thereby maintaining its dominance in the LAMEA market. However, the Bioresorable Vascular Scaffold segment would grow at the highest CAGR.

Europe Continuous Glucose Monitoring Systems (CGMS) Market Segmentation

The component segment of the CGMS market includes transmitters and receivers, sensors and CGMS compatible insulin pumps. Sensors market was the major segment with largest market share, with revenue of $101.3 million in 2015 and is anticipated to register a CAGR of 30.0% during the forecast period.

The CGMS devices have witnessed continuous technological evolution CGMS with smartphone connectivity. Wearable CGMS is another promising product with tremendous potential within the wearable healthcare devices. Non-invasive CGMS such as Symphony CGM System, due to its user-friendliness, extensive applications and FDA approvals for the same, have gained prominence over the years.

The report highlights the adoption of Continuous Glucose Monitoring Systems in Europe.Based on the Component, the Europe Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are Germany, UK, France, Russia, Spain, Italy and Rest of Europe region.

Europe Continuous Glucose Monitoring Systems (CGMS) Market Key Companies

Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.

Research Scope

The market is segmented based on Component, End User and Country.

Europe Continuous Glucose Monitoring Systems (CGMS) Market Segmentation

Europe Continuous Glucose Monitoring Systems Market, by Component

• Hardware
• Software
• Services

Europe Continuous Glucose Monitoring Systems Market, by End User

• Displays Terminals
• Interface Software
• Industrial PCs
• Other Controllers

Europe Continuous Glucose Monitoring Systems Market, by Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Company Profiles

• Roche Diagnostics
• Abbott Laboratories
• Dexcom Inc.
• Novo Nordisk
• Ypsomed AG
• GlySens Incorporated
• Medtronic Plc and
• Johnson & Johnson

Unique Offerings from KBV Research

• Exhaustive coverage of Europe Continuous Glucose Monitoring Systems (CGMS) Market
• Unique “Market Research & Analytics Tool” to provide instant comparative analysis within the report
• Subscription based model available
• Free of cost quarterly updates
• Free of cost automatic pdf report generation
• Guaranteed best price
• Assured post sales research support with 10% customization free

Chapter 1-Market Scope & Methodology

1.1  Market Definition

1.2  Objectives

1.3  Market Scope

1.4  Segmentation

1.4.1  Europe Continuous Glucose Monitoring Systems Market, by Component

1.4.2  Europe Continuous Glucose Monitoring Systems Market, by End User

1.4.3  Europe Continuous Glucose Monitoring Systems Market, by Country

1.5  Methodology for the research

Chapter 2.  Market Overview

2.1  Introduction

2.2  Key Influencing Factors

2.2.1  Drivers

2.2.2  Restraints

2.2.3  Opportunities

2.3  Europe Continuous Glucose Monitoring Systems Market

2.3.1  Europe Continuous Glucose Monitoring Systems Market – By Component

2.3.2  Europe Continuous Glucose Monitoring Systems Market – By End User

Chapter 3.  Europe Continuous Glucose Monitoring Systems Market – By Component

3.1  Europe Continuous Glucose Monitoring Systems Sensors Market – By Country

3.2  Europe Continuous Glucose Monitoring Transmitters & Receivers Market – By Country

3.3  Europe Continuous Glucose Monitoring Systems Integrated Insulin pumps Market – By Country

Chapter 4.  Europe Continuous Glucose Monitoring Systems Market – By End User

4.1  Europe Diagnostic centers/clinics Continuous Glucose Monitoring Systems Market – By Country

4.2  Europe ICUs Continuous Glucose Monitoring Systems Market – By Country

4.3  Europe Home Healthcare Continuous Glucose Monitoring Systems Market – By Country

Chapter 5.  Europe Continuous Glucose Monitoring Systems Market – By Country

5.1  Germany Continuous Glucose Monitoring Systems Market

5.1.1  Germany Continuous Glucose Monitoring Systems Market – By Component

5.1.2  Germany Continuous Glucose Monitoring Systems Market – By End User

5.2  UK Continuous Glucose Monitoring Systems Market

5.2.1  UK Continuous Glucose Monitoring Systems Market – By Component

5.2.2  UK Continuous Glucose Monitoring Systems Market – By End User

5.3  France Continuous Glucose Monitoring Systems Market

5.3.1  France Continuous Glucose Monitoring Systems Market – By Component

5.3.2  France Continuous Glucose Monitoring Systems Market – By End User

5.4  Russia Continuous Glucose Monitoring Systems Market

5.4.1  Russia Continuous Glucose Monitoring Systems Market – By Component

5.4.2  Russia Continuous Glucose Monitoring Systems Market – By End User

5.5  Spain Continuous Glucose Monitoring Systems Market

5.5.1  Spain Continuous Glucose Monitoring Systems Market – By Component

5.5.2  Spain Continuous Glucose Monitoring Systems Market – By End User

5.6  Italy Continuous Glucose Monitoring Systems Market

5.6.1  Italy Continuous Glucose Monitoring Systems Market – By Component

5.6.2  Italy Continuous Glucose Monitoring Systems Market – By End User

5.7  Rest of Europe Continuous Glucose Monitoring Systems Market

5.7.1  Rest of Europe Continuous Glucose Monitoring Systems Market – By Component

5.7.2  Rest of Europe Continuous Glucose Monitoring Systems Market – By End User

Chapter 6.  Company Profile

6.1  Roche Diagnostics.

6.1.1  Company Overview

6.1.2  Financial Analysis

6.1.3  Segmental Analysis

6.1.4  Research & Development Analysis

6.2  Abbott Laboratories

6.2.1  Company Overview

6.2.2  Financial Analysis

6.2.3  Segmental Analysis

6.2.4  Research & Development Analysis

6.3  Dexcom, Inc.

6.3.1  Company Overview

6.3.2  Financial Analysis

6.3.3  Research & Development Analysis

6.4  Novo Nordisk.

6.4.1  Company Overview

6.4.2  Financial Analysis

6.4.3  Segmental Analysis

6.4.4  Research & Development Analysis

6.5  Ypsomed AG

6.5.1  Company Overview

6.5.2  Financial Analysis

6.5.3  Segmental Analysis

6.6  GlySens Incorporated.

6.6.1  Company Overview

6.7  Medtronic Plc

6.7.1  Company Overview

6.7.2  Financial Analysis

6.7.3  Segmental Analysis

6.7.4  Research & Development Analysis

6.8  Johnson & Johnson.

6.8.1  Company Overview

6.8.2  Financial Analysis

6.8.3  Research & Development Analysis

6.8.4  Segmental Analysis

List of Tables

TABLE 1  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 2  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 3  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 4  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 5  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 6  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 7  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 8  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 9  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 10  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 11  EUROPE CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 12  EUROPE CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 13  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 14  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 15  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 16  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 17  EUROPE DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 18  EUROPE DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 19  EUROPE ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 20  EUROPE ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 21  EUROPE HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 22  EUROPE HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 23  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 24  EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 25  GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 26  GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 27  GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 28  GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 29  GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 30  GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 31  UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 32  UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 33  UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 34  UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 35  UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 36  UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 37  FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 38  FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 39  FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 40  FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 41  FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 42  FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 43  RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 44  RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 45  RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 46  RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 47  RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 48  RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 49  SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 50  SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 51  SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 52  SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 53  SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 54  SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 55  ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 56  ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 57  ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 58  ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 59  ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 60  ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 61  REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 62  REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 63  REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 64  REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 65  REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 66  REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 67  KEY INFORMATION – ROCHE DIAGNOSTICS.

TABLE 68  KEY INFORMATION – ABBOTT LABORATORIES.

TABLE 69  KEY INFORMATION – DEXCOM, INC.

TABLE 70  KEY INFORMATION – NOVO NORDISK.

TABLE 71  KEY INFORMATION – YPSOMED AG.

TABLE 72  KEY INFORMATION – GLYSENS INCORPORATED.

TABLE 73  KEY INFORMATION – MEDTRONIC PLC

TABLE 74  KEY INFORMATION – JOHNSON & JOHNSON.